Search Contract Opportunities

Pharmaceutical Prime Vendor Global   2

ID: SPM2DP-13-R-0007 • Type: Presolicitation

Description

Posted: Oct. 31, 2013, 4:02 p.m. EDT
Amendment 0002
Posted: Oct. 29, 2013, 4:49 p.m. EDT
Posted: Sept. 16, 2013, 1:00 p.m. EDT
Posted: Sept. 4, 2013, 1:16 p.m. EDT
Posted: Aug. 20, 2013, 10:37 a.m. EDT
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is hereby soliciting offers to select Pharmaceutical Prime Vendor (PPV) distributors to provide pharmaceutical products for the PPV Re-Solicitation (PPV-RS). PPV-RS refers to the Program name. The Regions are: North/Europe, South/Southcom, West/Pacific, Designated Providers (DPs)/Other Government Agencies (OGAs), Upper Prairie (Small Business Set-Aside), and a Back-Up Supplier (BS). The PPV will need to provide next day deliveries (Mon-Fri) to the PPV customers. The PPV is also required to supply War Readiness Material (WRM) requirements as cited in the Statement of Work (SOW).
The awarded contractor will be responsible to furnish pharmaceutical products in accordance with the specified ordering, packaging, shipping, receiving, and unique requirements as stated in the solicitation. This acquisition will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database. One or more of the items under this acquisition is subject to Free Trade Agreements.
The PPV contract will have a base period of thirty months and three thirty month option periods for a potential ten (10) year contract. The estimated contract value including all options is $26.1B. Under this solicitation, the awarded contractor will be responsible to furnish pharmaceutical program items ordered by the Ordering Facility(s).
This acquisition will result in a Firm Fixed-Price Requirements Contract(s). Competition will be sought, promoted, and sustained through the issuance of a competitive Request for Proposal (RFP) on a full and open competition basis (except for the Upper Prairie Region, which is reserved as a Small Business Set-Aside).
The Government intends to make multiple Primary Supplier awards for this procurement. The intent is to have at least two different contractors awarded under the unrestricted portion of this solicitation. This course of action will ensure that no one Primary Supplier receives an award for all of the Military Services' pharmaceutical requirements. This diversification increases the Department of Defense's access to vital pharmaceuticals during times of contingency or natural disasters. Global regions have similar but different dollar values. The offerors may propose offers combining Regions i.e. Region 0001 and 0002, Regions 0001 and 0003, Regions 0002 and 0003, and can add line 0004 (DPs/OGAs) to any of the aforementioned combinations. The Government cannot predetermine the order that lines will be awarded. The Government will make awards based on the evaluation criteria cited in the solicitation. However, the Government reserves the right to make awards of multiple lines to the same contractor, if the Government deems that it is in the Government's best interest. In order to ensure that multiple sources are available and to ensure the continuous availability of reliable sources of supplies, the Government reserves the right to exclude, under the authority of FAR 6.202, an awardee under this solicitation from being eligible for multiple lines under this solicitation.
This is a Lowest Price Technically Acceptable (LPTA) Acquisition. DLA Troop Support will make an award to the responsive and responsible offeror whose proposal is determined to be technically acceptable and provides the lowest overall price to the Government considering the base and all option periods. Lowest Price is based on best overall distribution fee computation. In addition to the LPTA, it is the intention of the Government to use the Reverse Auction strategy to obtain the best distribution fee possible. The offeror is required to submit its distribution fees for each line item as stated above. The Reverse Auction process may be used to determine the final distribution fees for purposes of evaluation for award.
Copies of the solicitation will be available on or about Sep. 04, 2013.
To obtain a copy of the solicitation, please visit the Federal Business Opportunities (FEDBIZOPPS) at https://www.fbo.gov/. Once the solicitation is available on FEDBIZOPPS it will remain open for 45 days. All responsible sources that submit a proposal will be considered by the Agency.

Overview

Response Deadline
Nov. 6, 2013, 3:30 p.m. EST (original: Sept. 5, 2013, 12:59 a.m. EDT) Past Due
Posted
Aug. 20, 2013, 10:37 a.m. EDT (updated: July 16, 2014, 3:53 p.m. EDT)
Set Aside
None
Place of Performance
Not Provided
Source
SAM

Current SBA Size Standard
250 Employees
Pricing
Fixed Price
Evaluation Criteria
Lowest Price Technically Acceptable (LPTA)
Est. Level of Competition
Average
Odds of Award
48%
On 8/20/13 DLA Troop Support - Medical issued Presolicitation SPM2DP-13-R-0007 for Pharmaceutical Prime Vendor Global due 11/6/13. The opportunity was issued full & open with NAICS 424210 and PSC 65.
Primary Contact
Title
Contracting Officer
Name
Patricia D. Kniffin   Profile
Phone
(215) 737-5097

Secondary Contact

Title
Contract Specialist
Name
Jayne A Bailie   Profile
Phone
(215) 737-6080

Documents

Posted documents for Presolicitation SPM2DP-13-R-0007

Question & Answer

Opportunity Lifecycle

Procurement notices related to Presolicitation SPM2DP-13-R-0007

Award Notifications

Agency published notification of awards for Presolicitation SPM2DP-13-R-0007

IDV Awards

Indefinite delivery vehicles awarded through Presolicitation SPM2DP-13-R-0007

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Presolicitation SPM2DP-13-R-0007

Similar Active Opportunities

Open contract opportunities similar to Presolicitation SPM2DP-13-R-0007

Additional Details

Source Agency Hierarchy
DEPT OF DEFENSE > DEFENSE LOGISTICS AGENCY (DLA) > DLA Troop Support - Medical
Source Organization Code
df74b76c034b388a514286abcc69be78
Last Updated
Nov. 28, 2014
Last Updated By
PI33_DR_IAE_51681
Archive Date
Nov. 28, 2014